This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Laurence Celine Menard: Innovator in Cancer Treatment
Introduction
Laurence Celine Menard is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic methods.
Latest Patents
Menard holds a patent for "TIM-3 antagonists for the treatment and diagnosis of cancers." This patent outlines methods for treating subjects afflicted with cancer by administering a TIM3 agonist, such as an anti-TIM3 antibody, either alone or in combination with another immune checkpoint inhibitor. The methods also include assessing the efficacy of the treatment by measuring the frequency of TIM3 positive cells in specific populations.
Career Highlights
Menard is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research in oncology. His work focuses on innovative approaches to enhance cancer treatment and improve patient outcomes.
Collaborations
One of his notable collaborators is Anke Klippel, with whom he has worked on various projects related to cancer therapies.
Conclusion
Laurence Celine Menard's contributions to cancer treatment through his patented methods exemplify the impact of innovation in medical research. His work continues to pave the way for advancements in the diagnosis and treatment of cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile